Universe Pharmaceuticals INC
UPC
$2.91
-$0.71-19.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -19.44M | -18.97M | -12.77M |
| Total Depreciation and Amortization | -- | -- | 485.60K | 499.80K | 504.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 11.50M | 11.34M | 5.96M |
| Change in Net Operating Assets | -- | -- | -2.06M | 1.01M | 3.82M |
| Cash from Operations | -- | -- | -9.51M | -6.11M | -2.50M |
| Capital Expenditure | -- | -- | -245.80K | -111.20K | -77.70K |
| Sale of Property, Plant, and Equipment | -- | -- | 1.80K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -117.20K | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -361.20K | -111.20K | -77.70K |
| Total Debt Issued | -- | -- | 17.32M | 9.62M | 7.65M |
| Total Debt Repaid | -- | -- | -8.36M | -7.03M | -7.04M |
| Issuance of Common Stock | -- | -- | 25.00M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 33.95M | 2.60M | 602.80K |
| Foreign Exchange rate Adjustments | -- | -- | 125.20K | -466.40K | -287.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 24.21M | -4.09M | -2.26M |